Literature DB >> 224124

Traumatic aneurysm of the internal carotid artery and epistaxis. (Review of literature and report of a case).

N A Mahmoud.   

Abstract

A review of 108 years of world literature revealed 69 cases fulfilling the picture of a clinical syndrome of head injury, a latent period followed by epistaxis and cranial nerve lesions. A similar case has been added which is the fourth case to be reported to be due to a bullet injury. The applied anatomy of the intracranial internal carotid artery (ICA) and the aetiology, clinical syndrome, pathology, diagnosis, prognosis and management of ICA aneurysms have been briefly discussed.

Entities:  

Mesh:

Year:  1979        PMID: 224124     DOI: 10.1017/s0022215100087508

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  Endovascular management of a carotid aneurysm into the sphenoid sinus presenting with epistaxis.

Authors:  Mohamed Akkari; Grégory Gascou; Vincent Trévillot; Alain Bonafé; Louis Crampette; Paolo Machi
Journal:  Interv Neuroradiol       Date:  2015-10-22       Impact factor: 1.610

2.  Massive recurrent epistaxis from non-traumatic bilateral intracavernous carotid artery aneurysms.

Authors:  A Karkanevatos; P D Karkos; Y G Karagama; P Foy
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-12-09       Impact factor: 2.503

Review 3.  Transcatheter embolization in the management of epistaxis.

Authors:  Gregory J Dubel; Sun Ho Ahn; Gregory M Soares
Journal:  Semin Intervent Radiol       Date:  2013-09       Impact factor: 1.513

4.  Traumatic Intracranial Aneurysm Formation following Closed Head Injury.

Authors:  Jefferson T Miley; Gustavo J Rodriguez; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2008-07

Review 5.  Traumatic intracranial aneurysms in childhood and adolescence. Case reports and review of the literature.

Authors:  E C Ventureyra; M J Higgins
Journal:  Childs Nerv Syst       Date:  1994-08       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.